averaged GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
UBP1 | hg19_v2_chr3_-_33481835_33481905 | 0.02 | 8.0e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr17_-_5138099 Show fit | 10.69 |
ENST00000571800.1
ENST00000574081.1 ENST00000399600.4 ENST00000574297.1 |
SLP adaptor and CSK interacting membrane protein |
|
chr7_+_142498725 Show fit | 9.70 |
ENST00000466254.1
|
T cell receptor beta constant 2 |
|
chr22_+_22707260 Show fit | 7.12 |
ENST00000390293.1
|
immunoglobulin lambda variable 5-48 (non-functional) |
|
chr6_+_32709119 Show fit | 6.00 |
ENST00000374940.3
|
major histocompatibility complex, class II, DQ alpha 2 |
|
chr2_-_89442621 Show fit | 5.11 |
ENST00000492167.1
|
immunoglobulin kappa variable 3-20 |
|
chr1_-_150208320 Show fit | 4.16 |
ENST00000534220.1
|
acidic (leucine-rich) nuclear phosphoprotein 32 family, member E |
|
chr6_+_31555045 Show fit | 3.59 |
ENST00000396101.3
ENST00000490742.1 |
leukocyte specific transcript 1 |
|
chr22_+_22676808 Show fit | 3.45 |
ENST00000390290.2
|
immunoglobulin lambda variable 1-51 |
|
chr2_+_113033164 Show fit | 3.07 |
ENST00000409871.1
ENST00000343936.4 |
zinc finger CCCH-type containing 6 |
|
chr19_-_51875523 Show fit | 2.73 |
ENST00000593572.1
ENST00000595157.1 |
natural killer cell group 7 sequence |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 10.7 | GO:0007127 | meiosis I(GO:0007127) |
0.1 | 9.7 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.1 | 8.4 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.1 | 6.0 | GO:0031295 | T cell costimulation(GO:0031295) |
0.1 | 5.6 | GO:0043486 | histone exchange(GO:0043486) |
0.0 | 5.2 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.2 | 5.1 | GO:0003094 | glomerular filtration(GO:0003094) |
0.1 | 3.6 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.0 | 3.6 | GO:0032945 | negative regulation of mononuclear cell proliferation(GO:0032945) negative regulation of lymphocyte proliferation(GO:0050672) |
1.2 | 3.5 | GO:0002370 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 10.7 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.2 | 9.7 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.3 | 6.0 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.3 | 5.6 | GO:0000812 | Swr1 complex(GO:0000812) |
0.0 | 5.3 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
1.7 | 5.1 | GO:0071748 | IgA immunoglobulin complex(GO:0071745) IgA immunoglobulin complex, circulating(GO:0071746) monomeric IgA immunoglobulin complex(GO:0071748) polymeric IgA immunoglobulin complex(GO:0071749) secretory IgA immunoglobulin complex(GO:0071751) |
0.0 | 4.8 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.2 | 3.6 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
0.1 | 2.8 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.2 | 2.0 | GO:0032039 | integrator complex(GO:0032039) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 10.0 | GO:0003823 | antigen binding(GO:0003823) |
0.2 | 9.7 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.4 | 6.0 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.1 | 5.6 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.0 | 5.2 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.0 | 3.6 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 2.8 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 2.1 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.0 | 1.7 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 1.7 | GO:0005178 | integrin binding(GO:0005178) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 5.3 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.0 | 3.6 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 1.5 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 1.2 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 1.2 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 1.0 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.0 | 0.5 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 0.4 | ST ADRENERGIC | Adrenergic Pathway |
0.0 | 0.3 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 6.0 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.1 | 4.9 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 2.8 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.0 | 2.4 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.0 | 1.7 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.0 | 1.2 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 1.0 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.0 | 0.9 | REACTOME CDK MEDIATED PHOSPHORYLATION AND REMOVAL OF CDC6 | Genes involved in CDK-mediated phosphorylation and removal of Cdc6 |
0.0 | 0.7 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.0 | 0.5 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |